# Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis

> **NCT00608322** · PHASE3 · COMPLETED · sponsor: **National Institute of General Medical Sciences (NIGMS)** · enrollment: 49 (actual)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Inhaled nitric oxide
- **OTHER:** Sham inhaled nitric oxide

## Key facts

- **NCT ID:** NCT00608322
- **Lead sponsor:** National Institute of General Medical Sciences (NIGMS)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2013-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00608322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00608322, "Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00608322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*